PCI BIOTECH HOLDING ASA (PCIB.OL) Forecast, Price Target & Analyst Ratings

OSL:PCIBNO0010405640

Current stock price

0.07 NOK
-0.04 (-39.13%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PCI BIOTECH HOLDING ASA (PCIB.OL).

Forecast Snapshot

Consensus Price Target

Price Target
N/A
N/A

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 29, 2026

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
N/A
Upside
N/A
From current price of NOK0.07 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

Analyst Ratings & History

Current Analyst Ratings

PCIB Current Analyst RatingPCIB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

PCIB Historical Analyst RatingsPCIB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
PCIB.OL was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PCIB.OL.
In the previous month the buy percentage consensus was at a similar level.
PCIB.OL was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 29, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024
Revenue
YoY % growth
PCIB.OL revenue by date.PCIB.OL revenue by date.
4.75M
-24.28%
2.99M
-37.05%
6.735M
125.25%
EBITDA
YoY % growth
PCIB.OL ebitda by date.PCIB.OL ebitda by date.
-50.041M
40.06%
-21.87M
56.30%
-17.652M
19.29%
EBIT
YoY % growth
PCIB.OL ebit by date.PCIB.OL ebit by date.
-56.447M
34.39%
-22.241M
60.60%
-17.955M
19.27%
Operating Margin
PCIB.OL operating margin by date.PCIB.OL operating margin by date.
-1,188.36%-743.85%-266.59%
EPS
YoY % growth
PCIB.OL eps by date.PCIB.OL eps by date.
N/AN/AN/A

All data in NOK

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in NOK

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PCIB.OL Yearly Revenue VS EstimatesPCIB.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
PCIB.OL Yearly EPS VS EstimatesPCIB.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 -0.5 -1 -1.5 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

PCI BIOTECH HOLDING ASA / PCIB.OL Forecast FAQ

What is the next earnings date for PCIB stock?

PCI BIOTECH HOLDING ASA (PCIB.OL) will report earnings on 2026-08-29.

How many analysts cover PCI BIOTECH HOLDING ASA (PCIB.OL) stock?

The number of analysts covering PCI BIOTECH HOLDING ASA (PCIB.OL) is 7.